Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,163 | 167 | 93.7% |
| Education | $211.29 | 8 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $483.87 | 23 | $0 (2023) |
| Antares Pharma, Inc. | $439.99 | 25 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $293.18 | 18 | $0 (2024) |
| NeoTract Inc. | $218.55 | 3 | $0 (2019) |
| PFIZER INC. | $192.22 | 11 | $0 (2024) |
| UROVANT SCIENCES INC | $191.48 | 10 | $0 (2022) |
| PROGENICS PHARMACEUTICALS, INC. | $139.99 | 7 | $0 (2024) |
| ABBVIE INC. | $129.75 | 8 | $0 (2022) |
| Allergan, Inc. | $105.75 | 1 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $87.32 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $418.40 | 23 | Sumitomo Pharma America, Inc. ($153.45) |
| 2023 | $600.86 | 31 | Sumitomo Pharma America, Inc. ($139.73) |
| 2022 | $647.70 | 33 | UROVANT SCIENCES INC ($131.99) |
| 2021 | $234.49 | 15 | UROVANT SCIENCES INC ($59.49) |
| 2020 | $192.70 | 8 | Allergan, Inc. ($105.75) |
| 2019 | $285.73 | 16 | Antares Pharma, Inc. ($92.00) |
| 2018 | $393.48 | 17 | NeoTract Inc. ($141.38) |
| 2017 | $600.49 | 32 | Astellas Pharma US Inc ($365.79) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/19/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: Prostate cancer | ||||||
| 11/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/06/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: UROLOGY | ||||||
| 06/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: HORMONE THERAPY | ||||||
| 03/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: UROLOGY | ||||||
| 03/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: HORMONE THERAPY | ||||||
| 03/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 02/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 02/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: UROLOGY | ||||||
| 02/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 01/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: HORMONE THERAPY | ||||||
| 12/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Urology | ||||||
| 11/13/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,992 | 55,379 | $297,832 | $105,440 |
| 2022 | 25 | 2,053 | 48,006 | $325,097 | $113,781 |
| 2021 | 29 | 2,054 | 51,782 | $422,328 | $141,402 |
| 2020 | 29 | 2,196 | 46,991 | $387,719 | $121,717 |
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 315 | $56,700 | $26,619 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 340 | $39,100 | $19,029 | 48.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 84 | $56,700 | $11,239 | 19.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 48 | 62 | $27,900 | $9,946 | 35.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 283 | 459 | $16,065 | $8,198 | 51.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $10,780 | $5,285 | 49.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 13 | 13 | $32,825 | $3,654 | 11.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 280 | 494 | $3,458 | $3,389 | 98.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 66 | $3,630 | $2,417 | 66.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 50 | 97 | $5,335 | $2,303 | 43.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 231 | $12,705 | $2,198 | 17.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 22 | $4,070 | $2,144 | 52.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $4,205 | $1,849 | 44.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 46 | 71 | $4,260 | $1,325 | 31.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 370 | 588 | $4,116 | $1,264 | 30.7% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 20 | 52,101 | $4,689 | $1,144 | 24.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 18 | $2,430 | $1,117 | 46.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 67 | 96 | $1,488 | $738.96 | 49.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 72 | 94 | $4,700 | $648.76 | 13.8% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 31 | 42 | $714.00 | $344.86 | 48.3% |
| 87088 | Bacterial urine culture | Office | 2023 | 31 | 42 | $1,092 | $322.82 | 29.6% |
| 80076 | Liver function blood test panel | Office | 2023 | 17 | 21 | $420.00 | $160.20 | 38.1% |
| 85014 | Red blood cell concentration measurement | Office | 2023 | 34 | 45 | $450.00 | $104.40 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 331 | $59,580 | $27,378 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 219 | 346 | $39,790 | $20,454 | 51.4% |
About Dr. Patrick Mills, MD
Dr. Patrick Mills, MD is a Urology healthcare provider based in Homewood, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700844263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Mills, MD has received a total of $3,374 in payments from pharmaceutical and medical device companies, with $418.40 received in 2024. These payments were reported across 175 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($3,163).
As a Medicare-enrolled provider, Mills has provided services to 8,295 Medicare beneficiaries, totaling 202,158 services with total Medicare billing of $482,340. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Homewood, AL
- Active Since 05/03/2006
- Last Updated 05/15/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1700844263
Products in Payments
- GEMTESA (Drug) $393.88
- XTANDI (Drug) $211.67
- XYOSTED (Drug) $201.59
- UroLift (Device) $197.77
- Myrbetriq (Drug) $182.90
- ORGOVYX (Drug) $173.62
- NOCDURNA (Drug) $153.06
- Xtandi (Drug) $146.14
- PYLARIFY (Drug) $139.99
- XIAFLEX (Biological) $85.60
- JELMYTO (Drug) $79.63
- Nubeqa (Drug) $76.52
- LUPRON DEPOT (Drug) $73.80
- GENTLECATH (Device) $66.62
- Erleada (Drug) $54.43
- SpeediCath (Device) $52.11
- KEYTRUDA (Biological) $49.33
- TLANDO (Drug) $44.52
- OTREXUP (Drug) $43.82
- ELIGARD (Drug) $42.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Homewood
Dr. Brian Christine, M.d, M.D
Urology — Payments: $521,154
Dr. Vincent Bivins, Md, MD
Urology — Payments: $138,864
Dr. Rupa Kitchens, Md, MD
Urology — Payments: $20,604
Alison Pickering, M.d, M.D
Urology — Payments: $17,153
Dr. Donald Bragg, M.d, M.D
Urology — Payments: $14,986
Dr. Mark Deguenther, M.d, M.D
Urology — Payments: $11,473